ArticleBMC infectious diseases2026
Malaria transmission dynamics, vector diversity, and insecticide resistance profiles in two health districts of southern Benin.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalaria transmission in Benin is heterogeneous, influenced by ecological settings and environmental changes affecting Plasmodium spp. prevalence, vector species composition, and insecticide resistance. Comprehensive local data on transmission dynamics remain limited, particularly in southern Benin. This study assessed malaria transmission, vector diversity, and insecticide resistance in two health districts to support the National Malaria Control Programme in designing targeted and effective vector control strategies.
methodsA repeated cross-sectional study was conducted in two health districts in southern Benin (Ouidah-Kpomasse-Tori Bossito (OKT) and Adjohoun-Bonou-Dangbo (ABD) districts). In OKT, blood samples were collected from August 2021 to August 2022, while in ABD sampling was conducted from July to November 2024. Human participants were screened for Plasmodium infections using microscopy and rapid diagnostic tests. Adult Anopheles mosquitoes were collected in both districts during rainy and dry seasons using human landing catches. Mosquitoes were morphologically and molecularly identified and screened for Plasmodium spp. Insecticide resistance was assessed through detection of kdr (L1014F) and ace-1 (G119S) mutations, and bioassays with pyrethroids (alpha-cypermethrin and deltamethrin) and synergists (PBO).
resultsA total of 1,962 participants were enrolled (OKT 1,577; ABD 385). Overall Plasmodium prevalence was 28.2% in OKT and 21.0% in ABD, with higher prevalence during the rainy season compared to the dry season in OKT (37.0% vs. 20.9%, p < 0.0001). Anopheles gambiae s.l. was the predominant species complex, with seasonal shifts in species composition determined molecularly; An. gambiae s.s. dominating in the rainy season (80.0% in OKT, 54% in ABD), while An. coluzzii predominated in the dry season (92.5% in OKT, 98.3% in ABD). High frequencies of kdr L1014F mutations were detected (0.62-0.93), whereas ace-1 resistance remained low (≤0.13). Plasmodium infection in mosquitoes was rare (<2%), and blood meals showed strong anthropophagy (97.8%). PBO bioassays indicated partial restoration of susceptibility to deltamethrin and alpha-cypermethrin.
conclusionsMalaria transmission in southern Benin remains sustained by high seasonal prevalence in humans, intense human-vector contact, and widespread pyrethroid resistance in vectors. Seasonal and spatial heterogeneity in vector species composition and resistance profiles highlight the need for adaptive, locally tailored control strategies, including monitoring and management of insecticide resistance. CLINICAL
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.